Pfizer axes two drug development programs
MarketWatch
"The decision to terminate these programs will enable the business unit to allocate additional resources to higher-potential development programs," said Pfizer in a statement. The decision was taken after the New York-based company decided that the …
Pfizer cancels development of two late-stage drugs Reuters
Pfizer Drops Two Late-Stage Drugs, Putting Resources Elsewhere Wall Street Journal
Pfizer drops development of 2 late-stage drugs The Associated Press
Business Wire (press release) - MSN Money
all 65 news articles